Attendees 参会企业

Thero天英汇总决赛—广州新同智创生物科技有限公司


项目名称:肿瘤个体化新抗原治疗

公司致力于肿瘤个体化新抗原诱导的T细胞疗法的临床转化,及诱导刺激物新抗原肽的生产与服务。

核心创始人为美国MD安德森归国的资深背景专家李凤娥博士,通过建立自有专利方法体系,通过药企、临床、海南自贸区的医疗机构提供给患者有效的治疗方式,并获得过诸多研发的同行评议的数据,且拥有独家的多肽信号的专利技术,服务营收承指数增长。

新同智创期待能给肿瘤患者提供最后一道治疗防线!

Cancer is characterized by an accumulation of genetic alterations. Somatic mutations can generate cancer-specific neoepitopes that are recognized by autologous Tcells as foreign and constitute ideal cancer vaccine targets. Every tumor has its own unique composition of mutations, with only a small fraction shared between patients.Technological advances in genomics, data science, and cancer immunotherapy now enable the rapid mapping of the mutations within a genome, rational selection of vaccine targets, and on-demand production of a therapy customized to a patient’s individual tumor. First-in-human clinical trials of personalized cancer vaccines have shown the feasibility, safety, and immunotherapeutic activity of targeting individual tumor mutation signatures.With vaccination development being promoted byemerging innovations of the digital age, vaccinating a patient with individual tumor mutations may become the first truly personalized treatment for cancer.


Contact Us

For more information, please contact at
Email: gzinnofestival@163.com
Telephone: 8620-83366321

如需更多信息和查询,请联系
官方邮箱:gzinnofestival@163.com
联系电话:8620-83366321

网站备案号:粤ICP备13032278号-2   技术支持:ASE Solution Company